Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationMice, Inbred C57BLHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsGraft RejectionTreatment OutcomeTime FactorsRemission InductionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseTransplantation ImmunologyBone Marrow NeoplasmsImmunosuppressionT-LymphocytesGraft vs Host ReactionLeukemia, MyeloidLymphocyte DepletionStem Cell TransplantationAcute DiseaseLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationSevere Combined ImmunodeficiencyHLA AntigensChimeraColony-Forming Units AssaySurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationCyclosporineHematologic DiseasesActuarial AnalysisLymphocyte TransfusionBone DensityMice, Inbred BALB CSpleenAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCell DifferentiationOrgan TransplantationCarmustineLeukocyte CountPancytopeniaGraft vs Tumor EffectFollow-Up StudiesCytomegalovirus InfectionsGraft vs Leukemia EffectFlow CytometrySurvival RateImmune SystemCytarabineCells, CulturedBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanDisease-Free SurvivalMice, KnockoutImmune ToleranceEtoposideLymphomaMultiple MyelomaFatal OutcomeInfectionAntigens, CD34Hodgkin DiseaseImmunophenotypingPrognosis